Evotec AG has achieved two milestones in a multiple target drug discovery collaboration with Shionogi & Co Ltd., triggering two undisclosed milestone payments to Evotec. The two companies will continue to collaborate to progress the fragments through the drug discovery process.   The collaboration was initiated in October 2010 to identify small molecule modulators of various protein-protein interaction targets selected by Shionogi. Evotec has applied its integrated fragment-based drug di...